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ABSTRACT
Background: Microalbuminuria, though a relevant 
screening tool world wide, is scarcely reported with very 
sparse literature in our setting. Microalbuminuria is a 
marker of  early renal involvement, compare to routine 
serum creatinine and electrolytes changes in hypertension 
and diabetes mellitus. This article attempts to review the 
significance, risk factors and methods of  detection of  
Microalbuminuria.
Methods: Available publications from local and 
international journals in addition to Medline and Google 
search, particularly for local references were utilized. Other 
sources of  our data included dissertations from the library 
of  National post graduate medical college and text books 
of  paediatric nephrology.
Results: Microalbuminuria is used extensively in diabetes 
mellitus as a sensitive test for the detection of  preclinical 
kidney dysfunction prior to the development of  overt 
proteinuria, and as a predictor of  subsequent diabetic 
 nephropathy. It has been found to be an important 
 prognostic indicator in meningitis, malignancy and 
hypertension. It has been found to be useful in the 
 monitoring of  patients with renal scarring, unilateral 
 nephrectomy and diabetes mellitus. It is also an important 
marker of  glomerular injury, particularly in patients with 
sickle cell anaemia.
Conclusion: Microalbuminuria is an early maker of  
glomerular injury. It is important as a screening tool in a 
variety of  disease conditions. Screening may be performed 
with a semiquantitative assay.  If  the screen is positive, 
UAE should be evaluated by a quantitative assay.
Key words: Microalbuminuria; Screening; Risk factors; 
Methods of  detection. 
Correspondence: Dr. L.E. Yaguo Ide
  
 E-mail: lucyaguo@yahoo.co.uk
quantities of  albumin can be detected in the urine using 
sensitive immunochemical techniques and this 
phenomenon is called Microalbuminuria. 
MICROALBUMINURIA
 Microalbuminuria (MA) which is a sub-clinical rise in the 
urinary albumin excretion has been defined variously by 
6 7 8 9Marshall , Mimran et al , Winocour  and Hasslacher et al . 
6Marshall  defined MA in terms of  timed overnight urine 
collections as an albumin excretion rate greater than 
6 720µg/minute . According to Mimran et al , however the 
term MA refers to a situation where the urine is albustix 
negative but positive for albumin with an excretion rate  in 
the range of  20-200µg/minute.( The lowest detection limit 
using conventional methods such as sulfosalicylic acid 
precipitation or bromophenol-blue reaction used in the 
8albustix test is > 200µg/minute ). Winocour , on the other 
hand defined MA as a ratio of  urinary albumin to urinary-
8creatinine greater than 3.0µg/mmol  which can readily be 
10, 11 9done on spot urine samples . While Hasslacher et al  
defined MA as albumin excretion in the urine within the 
range of  20mg/l to 200mg/l. 
The concept of  Microalbuminuria was introduced more 
than 30years ago when measures to detect urinary albumin 
below the level detectable by conventional urinary dipstick 
became available. MA was subsequently shown to be an 
early marker of  diabetic nephropathy. It was also found, 
quite remarkably to be a stronger predictor of  
cardiovascular mortality than of  renal events. In the Heart 
Outcomes prevention Evaluation (HOPE) study, 
Microalbuminuria was the strongest predictor of  
cardiovascular events in a high-risk population with 
underlying atherosclerosis. It was found to be stronger than 
other risk factors such as coronary artery disease and 
12diabetes .  It is important to appreciate Microalbuminuria 
not only predicts cardiovascular but also other 
13atherosclerotic vascular events. Miettnen et al  followed 
over 2,000 diabetic and non-diabetic patients for 7 years, 
looking at the association between the different degrees of  
proteinuria and atherosclerotic vascular events. In both 
groups, Microalbuminuria was associated with incidence 
of  cardiovascular events  stroke and aggregate vascular 
events. Compared to earlier documented traditional risk 
factors, Microalbuminuria has been shown to be a strong 
predictor of  cardiovascular death even in healthy 
14populations . In a cohort of  healthy individuals, Borch-
14Johnsen et al  prospectively followed more than 2,000 
patients for 10 years. The participants had no ischemic 
heart disease or diabetes. In this study, Microalbuminuria 
was associated with increased relative risk of  
cardiovascular death by 2.3-fold, independent of  other risk 
factors.
Microalbuminuria: It's Significance, risk factors and methods of detection
INTRODUCTION
Dipstick urinalysis is a valuable tool in the screening of  
1-5urinary abnormalities,  as it detects proteinuria, 
haematuria, urinary specific gravity, leukocyturia among 
other things. It, however, cannot detect early renal changes 
that may be heralded by proteinuria in the range of  20-
200mg/l (microalbuminuria). Long before one obtains a 
positive urine test for protein using the albustix, small 
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15In patients aged more than 40 years, Yudkin et al ,  observed 
that within a mean follow-up period 3.6 years, cardiovascular 
complications ( coronary artery disease or peripheral arterial 
disease ) were more frequent in patients with 
Microalbuminuria as compared with those without it; 30 
percent versus 74 percent for coronary disease and 10 percent 
versus 44 percent for peripheral diseases. Moreover, death 
was more frequent in those with Microalbuminuria (2 percent 
versus 33)
 MA has been found to be an important prognostic indicator 
16 17 18 in meningitis,  malignancies  and hypertension  It has 
been found to be very useful in the monitoring of  patients 
19 20,21 with renal scarring,  unilateral nephrectomy  and 
22,23  diabetes mellitus.  MA has also been found to be an 
important  marker of  glomerular injury, particularly in 
patients with sickle cell anaemia prone to nephropathy
The term sickle cell nephropathy encompasses all the 
structural and functional abnormalities such as proteinuria 
24,25 26,27  with or without nephrotic syndrome,  hyposthenuria,  
25,28 24,29 incomplete distal tubular acidosis,  haematuria,  
30,31 immune complex glomerulonephritis,  and progressive 
28, 29 renal failure. These manifestations are as a result of  
chronic renal micro-vascular occlusion by sickled 
32, 33  erythrocytes. the effect of  which is accentuated during 
34,35  crises . The renal microvasculasure is particularly 
36 vulnerable because of  absence of  collateral circulation and 
the characteristic sickling promoting features of  renal 
medulla, which include hypoxia, acidosis and 
18,25,37,38  hypertonicity . Sickle cell nephropathy may present as 
39 urinary abnormalities detectable by dipstick urinalysis or in 
case of  early glomerular involvement by MA detection.
Studies on urinary abnormalities among various populations 
of  children in Nigeria have been carried out using the dipstick 
40-50  urinalysis .Findings from these studies include, proteinuria 
in one to seventy percent of  apparently normal neonates and 
40-50  children of  varying ages .  Significant haematuria was 
40-50  reported in 0.6-4% of  normal children studied . Ugwu and 
40 Eke  in the course of  their randomized study for suitable 
malaria prophylaxis amongst children with sickle cell 
anaemia (SCA) at the University of  Port Harcourt Teaching 
Hospital did weekly interval urinalyses among 72 children 
aged 16months -16years and found significant haematuria 
and proteinuria of  one and seven percent respectively; and all 
patients with abnormal urinary findings were above the age 
51 of  5yrs. In terms of  MA, Ibadin et al  in their study at the 
University of  Benin Teaching Hospital (UBTH) to determine 
the prevalence of  Microalbuminuria in adolescent/young 
adult offspring's  of  Nigerian hypertensive adults worked on 
42 subjects aged between 13 and 24years, using micral-test 
strips. Nineteen percent had Microalbuminuria in their spot 
urine, as compared to 8 percent in controls. The incidence of  
Microalbuminuria was more in the age bracket 16-18years. It 
was also more in subjects with positive paternal history of  
hypertension (21.1% as against zero percent in those with 
positive maternal history of  hypertension)
Microalbuminuria is believed to be an important marker of  
glomerular injury in patients with sickle cell anaemia. Few 
studies on Microalbuminuria in sickle cell anaemia patients 
have been done. The prevalence of  Microalbuminuria in 
sickle cell anaemia patients has been shown to vary in 
 22,23,52-54different settings.  Studies  have recorded prevalence 
rates of  between 19  40%. The prevalence of  
Microalbuminuria was found to be 42.7%, 20.3% and 18.5% 
among paediatric patients with Sickle cell anaemia in Port 
Harcourt, Benin and Enugu respectively using the micral test 
58-60strip . Microalbuminuria occurs sufficiently enough in both 
children and adults to warrant routine screening. Such 
measures may assist in early detection and improve case 
management of  patients who are prone to renal 
complications as interventional measures known to retard the 
rate of  deterioration could be instituted.
RISK FACTORS FOR MICROALBUMINURIA;
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61Table 1:  Risk Factors Associated with Elevated Albuminuria .
Modifiable   Non modifiable 
Well documented Likely 
Race/ethnicity                     Diabetes Hyperlipidemia 
Male gender                         Hypertension                                      High salt (and protein ) diet 
Older age                               Obesity Oral contraceptives 
Low birth weight                   Smoking   Hormone replacement therapy 
Risk factors associated with elevated albuminuria are 
shown in Table I below. 
Mechanisms underlying progressive loss of renal 
function.
 It has been documented that the haemodynamic adaptations 
of  glomerular hypertension and hyperfilteration in remnant 
nephrons (i.e. those nephrons not damaged by the initiating 
62renal disease) ultimately prove detrimental . They suffer 
progressive glomerulosclerosis, a process that sets into 
motion a vicious cycle of  nephron loss. The more initial 
nephrons lost, the more the haemodynamic burden to the 
62remaining ones . The ensuing protein leakage through these 
affected glomeruli results in enhanced tubule protein 
reabsorption, which initiates progressive tubule atrophy and 
63interstitial fibrosis . Clinically, the most important factors 
promoting this final common pathway of  progressive 
6 4 6 5nephron loss are hyper tension , proteinuria ,  
66 67hyperlipidemia , and genetic factors such as race . Other 
68 69 70factors such as obesity , smoking , low birthweight , male 
71gender  and high salt intake are also to be associated with a 
worse outcome in subjects with preexisting renal disease. 
These are shown in Table I above.
Nonmodifiable risk factors associated with a higher 
urinary albumin excretion
72-73a) Race/ethnicity:  Various reports  have documented a 
higher prevalence of  an elevated albumin excretion in specific 
ethnic groups. Recent studies suggest that the racial and 
geographic disparities in ESRD, and the increasing incidence 
rates, may have a fetal origin as indicated by an association 
72-74 75with birth weight (BW) . Brenner et al , proposed a 
mechanism involving impaired kidney development in utero 
as an explanation for reduced renal function later in life. b) 
Male Gender/Old age :  It has been documented that 
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elevated albumin excretion is found more frequently in men 
74-76than women , this difference is age dependent. 
Urinary albumin excretion is significantly higher in men than 
74-77women, especially at older age . In the normal population, 
GFR decreases from the age of  30 by about 
780.8ml/min/year . Assuming that a 30-year-old subject has a 
normal GFR of  about 120ml/min, his/her GFR will be 
about 70ml/min at age of  80. A renal biopsy from that 80-
year-old person will typically reveal some atrophic glomeruli 
with tubule atrophy, other glomeruli showing signs of  
glomerulosclerosis and still others showing glomerular 
enlargement and hypertrophy.
c) Low Birth Weight: With respect to low birth weight, an 
inverse association between Microalbuminuria and height 
was found, arguing that factors operating in utero or early 
71, 74, childhood influence urinary albumin excretion in later life
79 75. Brenner et al , proposed a mechanism involving impaired 
kidney development in utero as an explanation for reduced 
71renal function later in life. Hoy et al , proposed that the 
association between low birth weight and renal disease might 
be mediated through impaired nephrogenesis caused by 
intrauterine malnutrition. 
Modifiable Factors that have been well documented in 
Relation to Albuminuria.
 a)  Diabetes:   Both glomerular hyperfilteration and a 
slightly elevated albumin excretion rate have been found 
to predict progressive renal failure in both type I and type 
27, 28, 80-822 diabetes . Albuminuria in both type I and type 2 
diabetes is associated with widespread endothelial 
dysfunction, manifest not only in the glomerular 
83-84vasculature, but in other vascular beds as well . 
 b)  Hypertension:  Increased urinary albumin loss has also 
85-86been linked to essential hypertension . Just as in 
diabetes, Microalbuminuria in essential hypertension 
has been taken to reflect widespread endothelial 
87dysfunction . Albuminuria in essential hypertension is 
associated not only with left ventricular hypertrophy, but 
88also with glomerular hyperfilteration . 
c) Obesity:    Elevated albumin excretion is frequently 
70, 89-91found in nondiabetic obese subjects . In obese 
subjects, the risk for glomerular hyperfilteration and 
89-91hyperperfusion is enhanced . The risk for glomerular 
hyperfilteration seems to be especially evident in cases of  
82, 89abdominal obesity .
d) Smoking:  Smoking is also associated with an increased 
risk for albuminuria. It has been shown that smoking is 
associated with an increased risk for both 
92hyperfilteration and impaired filteration . Life time 
tobacco exposure, but not current level of  smoking, is 
associated with renal function impairment and 
93proteinuria .
Modifiable Factors which are likely to be Related to 
Albuminuria
 a)  Hypercholesterolemia: The Gubbio study, showed that 
the risk for elevated albumin excretion increased 2-fold 
91for each 40mg/dl increase in plasma cholesterol . 
Moreover, it has been shown that hypertensive subjects 
with high cholesterol levels have a more rapid decline in 
94GFR over time .
b)  Dietary salt intake:    A higher salt intake is 
independently associated with a higher urinary albumin 
95excretion . It also predicts mortality and the risk for 
96coronary disease .
c)  Oral Contraceptives and Hormone Replacement 
Therapy: The use of  oral contraceptives and hormone 
97-98replacement therapy , is also associated with an 
enhanced urinary albumin excretion .Users of  oral 
contraceptives had an increased renal vascular resistance 
99and filtration fraction .
Factors Affecting Urine Albumin Excretion in Children
100Albuminuria is affected by exercise and posture . They 
cause increase in the excretion of  albumin in urine. Albumin 
101demonstrates a day to day variability . Urine albumin 
excretion (UAE) tends to be approximately 25 percent greater 
during the day than the night and shows a daily variation of  
10240-100 percent in children . Other factors which increase 
103 74, 104UAE are obesity , puberty , excessive alcohol intake and 
105smoking . Physiological factors such as exercise, posture 
and diuresis increase UAE other factors like urinary tract 
106infection and acute illness also increase UAE .  In children 
107age 5-18 years UAE is higher in females than males  and 
does not differ with age in either sex below the age of  5 
107years . In adults the converse is true; i.e. women have lower 
74albumin excretion than men . A negative correlation has 
74been shown between UAE and height
.
Review of Methods Available for the Detection and 
Measurement of Albumin :   Variations in urine flow rate in 
a person may be corrected by the expression of  albumin as a 
ratio to creatinine  ( that is albumin/creatinine) 
All the following urine samples are currently acceptable:
1. 24-hour collection 
2. Overnight ( 8-12-hour ) collection
3. 1-2-hour collection ( in laboratory or clinic)
4. First morning sample for simultaneous albumin and 
creatinine measurements.
The timed specimen ( 24-hour or overnight ) are the most 
sensitive but the albumin- to- creatinine ratio is more practical 
and convenient for  the patient. At least three separate 
samples should be assayed because of  the high 
intraindividual variation (30% -50% ) and diurnal variation 
(50% to 100%) higher during the day. Urine should be stored 
at 4°C after collection. Alternatively, 2ml of  50g/l sodium 
azide can be added per 500ml of  urine, but preservatives are 
not recommended for some assays. Bacterial contamination 
and glucose have no effect.
Semiquantitative assays.
A number of  semiquantitative assays for screening for 
increased UAE are available. These test strips, most of  which 
are optimized to read  “ positive” at a predetermined albumin 
concentration, are suitable for screening programs. Because 
of  the avide variability in UAE, a “normal” value does not 
exclude renal disease. Because these assays measure albumin 
concentration, dilute urine may yield a false  negative result. 
Refrigerated urine samples should be allowed to reach at least 
10°C before analysis. Albu Screen and Albu Sure detect 
urinary albumin concentration above 20 and 30 mg/l, 
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respectively. The assay is a latex agglutination inhibition test. 
Briefly, one drop of  urine is mixed with one drop of  goat 
antihuman albumin, the titer of  which is adjusted so that all 
anti-body binding sites are occupied at urinary albumin 
concentration of  30mg/l or greater. Excess albumin binding 
sites are detected by the addition of  one drop of  albumin-
coated latex microspheres and subsequently rocking for 2 
minutes. Albumin concentrations less than 20mg/l produce 
agglutination. Sensitivity and specificity are reported to be 
approximately 90% to 95%. Micro-bumintest uses 
bromophenol blue in an alkaline matrix to detect albumin 
concentration exceeding 40mg/l. The assay sensitivity is 
approximately 95%, but specificity is approximately 80%.
In the Micral test strip a monoclonal antialbumin IgG is 
complexed to â-galactosidase. The albumin in the urine binds 
to the antibody-enzyme conjugate in the test strip. Excess 
conjugate is retained in the separation zone containing 
immobilized albumin, and only albumin bound to antibody-
enzyme immunocomplex diffuses to the separation zone. 
There it reacts with a buffered substrate ( chlorophenol red 
galactoside ) to produce a red colour when the â-
galactosidase hydrolyzes galactose. The test strip is dipped 
into the urine for 5 seconds, and the intensity of  the color after 
5 minutes is proportional to the urinary albumin 
concentration. Direct visual comparison is made with printed 
color blocks-yellow, light brown, medium brown, brick red, 
and burgundy, representing 0,10,20,50 and 100mg/l 
respectively. Comparison with a reference method 
demonstrates a sensitivity and specificity of  approximately 
100% and 91% respectively. Both the time  the stick is in 
contact with the urine and the time of  reading are critical.
A modification (Micral 11) uses gold-labeled instead of  
enzyme-labeled antibody. This method enhances the stability, 
allowing the strip to be read at any time from 1 to at least 60 
minutes. Urine specimens with albumin concentrations 
greater than 100-300mg/l may be diluted and reassayed. The 
assigned concentration of  the color block is multiplied by the 
dilution factor to obtain the concentration in the sample. 
These semiquantitative assays are suitable for screening only 
and are not sufficiently accurate for regular monitoring of  
patients.
Quantitative Assays:
All the sensitive, specific assays for urine albumin use 
immunochemistry with antibodies to human albumin. Four 
m e t h o d o l o g i e s  a r e  av a i l a b l e  R I A ,  E L I S A ,  
radioimmunodiffussion and immunoturbidometry. Each 
method has advantages and disadvantages, and the choice 
depends on local experience and technical support. All 
methods have similar precisions, sensitivity, and range. 
Although dye-binding and protein precipitation assays have 
been described, these are insensitive and nonspecific and 
should not be used.
Radial immunodiffusion:
This is a reliable and inexpensive method but is unlikely to 
gain wide acceptance because it requires a long incubation 
period and high level of  technical skill and cannot be 
automated. The antibody is incorporated into an agar gel. 
Aliquots of  samples and calibrators are added to wells and 
allowed to diffuse into the agar. Antigen-antibody complexes 
precipitate at equilibrium, and the distance of  migration is 
measured after staining.
Radioimmunoassay (RIA):
Standard RIA  is performed in the liquid phase in the 
125presence of  excess antigens. I-labeled albumin and 
antialbumin antiserum are used, with separation of  bound 
from free by the double-antibody technique. The sample 
values are determined by comparison with a calibration 
curve. Assays are sensitive, precise and inexpensive but 
reagents are radioactive and have short shelf  lives. 
Commercial kits are available.
Enzyme-linked immunosorbent assay:
Both competitive and “sandwich” ELISAs are available. 
Although the competitive ELISA is faster because it uses only 
one incubation with antibody, it is reportedly less sensitive 
and exhibits large variance. ELISA can be performed on a 
microplate reader, allowing semiautomation. In the 
sandwich assay the primary antibody ( antialbumin 
antiserum) is fixed on the plastic plate, which is then washed. 
Samples, controls and calibrators are added, and the 
complexes detected and quantified by a second antibody are 
conjugated to an enzyme label.
Immunoturbidometry:
Albumin in the urine sample forms an insoluble complex 
with antibodies to human albumin. The turbidity caused by 
the complexes is spectrophotometrically measured at 340nm 
and provides a measure of   albumin concentration. The 
background absorbance of  the initial urine sample is 
automatically subtracted.  This method is simple and less 
expensive than RIA, and rapid analysis of  large numbers of  
samples is possible. The assays may be performed as either 
kinetic or equilibrium reactions. Kits are commercially 
available to be used on automated analyzers.
High antigen concentrations may cause a “hook” effect, 
resulting in falsely low concentrations. This effect can be 
avoided by screening of  urine samples with a dipstick but may 
not be necessary if  the analyzer automatically test for antigen 
excess.
A urinary tract infection or contamination with seminal or 
menstrual fluid may produce false-positive results. High 
Condition �� g/min mg/24h Corrected(mg/g urine 
creatinine)  
Normal <20  <30  <30  
Increased UAE 20-200 30-300 30-300 
Macroalbuminuria >200  >300  >300  
2+physiological Ca  concentrations in the urine falsely increase 
albumin values. The interference is abolished by the addition 
of  EDTA, which has been incorporated into  commercial 
assay.
Reference: intervals interval for Microalbuminuria is as 
shown below:
The Nigerian Health Journal, Vol. 11, No 1, January - March  2011 Page 04
Yaguo Ide L.E  - Microalbuminuria: A Review
CONCLUSION
Microalbuminuria is an early maker of  glomerular injury. 
Screening may be performed with a semiquantitative assay.  
If  the screen is positive, UAE should be evaluated by a 
quantitative assay.
If  the confirmatory test is positive, treatment with an 
angiotensin-converting enzyme (ACE) inhibitor would 
retard the Microalbuminuria and prevent progression to overt 
renal failure.
Recommendation
Paediatric patients should undergo periodic screening for 
Microalbuminuria . 
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